Inventing a drug is one of the most challenging, expensive and prolonged initiatives that is undertaken in the life sciences. The definition of a “drug” is changing dramatically and is now much broader than small molecules and biologics. This calls for both different discovery and development approaches, and enhanced collaboration across the biopharmaceutical industry, government and academia. In this webinar, Dr. Michael Rosenblatt, Chief Medical Officer at Flagship Pioneering (and former Chief Medical Officer at Merck) will discuss novel, innovative approaches to drug invention and how they complement established approaches.